A. COLLIE, P. MARUFF135
Inclusion and exclusion criteria
Memory impairment
All published classification systems propose as aninclusion criterion evidence of a memory deficit (Table3).This arises from repeated findings that memory is thefirst cognitive domain affected by the AD process [2,3,6],and is also affected by the normal ageing process [7].However, the classification systems differ as to whetherthe memory impairment needs to be identified objec-tively. For example, the Age-Associated Memory Impair-ment (AAMI) and Mild Cognitive Impairment (MCI)criteria require that memory test performance be abnor-mal relative to a control group, whereas the Age-RelatedCognitive Decline (ARCD) criterion requires only a sub- jective report of problems recalling names and events. Of those classification systems that require objective evi-dence of a memory deficit, there are differences betweenthe composition of the group against which memory testperformance is compared. For example, the comparisongroup specified by the AAMI criterion is normal youngadults, whereas the MCI criterion requires an age-appropriatecontrol group. Healthy young people gener-ally have superior memory test performance than healthyolder people [7], and it is therefore likely that a greaterproportion of older individuals will be classified asimpaired when the AAMI criterion is employed. Thecomposition of groups of impaired subjects classifiedaccording to AAMI and MCI criteria are also likely to bedifferent, and their relationships to outcome measures(e.g. prevalence, progression to AD) not comparable [4].
Other cognitive impairment
Some classification systems propose that memoryimpairment be accompanied by deficits in other cog-nitive domains, although this is not required universally(Table3). For example, an individual can be classified ashaving Questionable Dementia (QD) when mild impair-ments are evident in a number of cognitive domains. Incontrast, the criteria for AAMI specifies that cognitiveprocesses other than memory remain unaffected. Deficitsin cognitive domains other than memory occur predom-inantly in more advanced stages of AD [8] or in otherneurodegenerative diseases (e.g. vascular dementia [9]),whereas the earliest stages of AD are characterized by anisolated memory impairment [3,10]. Therefore, classifi-cation systems which require impairment in multiplecognitive domains are likely to identify individuals in
Table2.Results from selected studies of older people classified as impaired according to different systems
Study System of Outcome ResultClassification measure
Smith
et al
. [5]AAMIPrevalence7–96% depending on memory test usedBarker and Jones [22]AAMIPrevalence15–58% depending upon criteriaBarker
et al
. [43]AAMIPrevalence5.8–15.8% depending on individual criteriaSoininen
et al
. [44]AAMIBrain volumeNormal hippocampal volume; hippocampal asymmetryForstl
et al
. [29]AAMIBrain volume
↓
hippocampal volumeLaakso
et al
. [45]AAMIBrain volumeNormal amygdala volumeKrasuski
et al
. [46]MCIBrain volume
↓
entorhinal, hippocampal, amygdale volumeJack
et al
. [47]MCIBrain volume
↓
hippicampal volumeTierney
et al
. [48]N/SClinical outcome24% develop AD 2years after baselineBowen
et al
. [40]IMLClinical outcome48% develop AD 31months after baselineBerent
et al
. [39]IMIClinical outcome50% develop AD 3years after baseline; 15% pseudodementiaPetersen
et al
. [2]MCIClinical outcome48% develop AD 2years after baselineForstl
et al
. [29]AAMIApoE genotype58% carry e4 allele;Blesa
et al
. [37]ARMDApoE genotype56% carry e4 allele; 37% e3/3 homozygous; 4% carry e2 alleleBartres-Faz
et al
. [49]AAMIApoE genotype18% carry e4 allele; 64% e3/3 homozygous; 18% carry e2 alleleHanninen
et al
. [50]AAMICognitive function
↓
executive function performanceFowler
et al
. [28]QDCognitive function43% display
↓
episodic memory function over 12 month periodPetersen
et al
. [2]MCICognitive function
↓
episodic memory performanceAAMI=Age-Associated Memory Impairment; MCI=Mild Cognitive Impairment; ARCD=Age-Related Cognitive Decline;IML=Isolated Memory Loss; IMI=Isolated Memory Impairment; QD=Questionable Dementia;
↓
=decreased; AD=Alzheimer’sdisease; ApoE=Apolipoprotein; N/S=system of classification system not specified. Results from studies of older people classifiedas having cognitive impairment can vary substantially according to the criteria used to classify impairment. This is true for a numberof different outcome variables, including estimated prevalence of impairment, brain volume measured with Magnetic ResonanceImaging, apolipoprotein E genotype, clinical outcome (the number of people subsequently meeting criteria for AD), andperformance on tests of cognitive function.
Leave a Comment